Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity

AUTHORS

Malene Rohrsted 1 , Cecilie Nordsten 1 , Per Bagi 1 , *

1 Department of Urology, Rigshospitalet, State University hospital, Copenhagen, Denmark

How to Cite: Rohrsted M, Nordsten C, Bagi P. Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity, Nephro-Urol Mon. 2012 ; 4(2):e93974.

ARTICLE INFORMATION

Nephro-Urology Monthly: 4 (2); e93974
Published Online: March 01, 2012
Article Type: Review Article
Received: May 18, 2019
Accepted: August 29, 2011
READ FULL TEXT

Abstract

Botulinum toxin (BT) is a potent presynaptic neuromuscular blocking agent which induces selective, reversible muscle weakness for months when injected intramuscularly.During recent years BT has revolutionized the treatment of previously intractable symptoms of detrusor overactivity. Based on a systematic search of the PubMed database,a review of the current literature on the use of onabotulinum toxin A (Botox®) in the treatment of neurogenic detrusor overactivity is presented.
Onabotulinum toxin A proved to be highly effective in the majority of studies, even though a wide range of injection techniques and dosages were described. The onset of the effect usually appeared before 2 weeks, and reached a peak within 2-6 weeks, with the clinical effect being maintained for approximately 6-8 months, or even longer. Depending on the dose, a number of patients developed high residual volume and clean intermittent self/helper catheterization (CIC) may become necessary. only a few side effects were described, and intravesical onabotulinum toxin A injection seems to be well tolerated. however, details on injection technique, dose interval between injections, etc.are still under debate and only a few randomized, placebo controlled studies have been published.

Fulltext

This part is available in the PDF file.

References

  • 1.

    The references are available in the PDF file.

  • © 2012, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: